According to a report on December 15th by Brazilian newspaper, O Globo, Philip Morris Brasil is putting pressure on Brazil's National Health Surveillance Agency (Anvisa) to regulate e-cigarettes in the country.
Last Tuesday (December 12th), Anvisa conducted a public consultation on the issue of e-cigarettes. Philip Morris Brazil quickly launched a voting campaign, advocating for the regulation of electronic products. The campaign was called "I Choose," and it opposed a legislative ban on e-cigarettes, listing reasons supporting the regulation of e-cigarettes.
Philip Morris of Brazil claims that for any smoker, the best choice is to quit smoking. However, if quitting is not possible, they should opt for smokeless products such as e-cigarettes, as these products entail lesser "potential harm" to health.
Rafael Bastos, the Senior Corporate Affairs Manager of Philip Morris Brazil, stated that "smoking e-cigarettes poses significantly less harm to one's health compared to traditional tobacco combustion, which is considered the worst way to consume nicotine.
In addition, he pointed out that currently Anvisa does not know what substances are contained in e-cigarettes, which is also due to the lack of transparency in the illicit market. This issue can be resolved by implementing compliance management for e-cigarettes.
A survey conducted by the investigation agency Ipec reveals that despite a ban on the use of electronic devices since 2009, approximately 2.2 million Brazilians are e-cigarette users.
Philip Morris believes that Brazilian consumers have already made their decision to use their product, regardless of its legality. Therefore, it is necessary to regulate in order to ensure the best possible manner of consumption.
These products are increasingly entering the country, and the reasons for their entry are very clear – because of demand. Today, the smuggling of e-cigarettes is providing funding for criminal gangs," said Bastos.
The public consultation by Anvisa on the subject will continue until February 9, 2024.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
